Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of autologous cord blood for neonatal cardiac and brain injury after surgery for congenital heart disease
MOH_2018-06-30_002484Phase 2Not yet recruiting
- Sponsor
- עמר בר יוסף
- Start
- Jun 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous umbilical cord blood in Cardiovascular Malformation (CVM), transposition of the great arteries (TGA) and hypoplastic left heart syndrome (HLHS) (2 arms), sponsored by עמר בר יוסף. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
autologous umbilical cord blood
03
Conditions
Cardiovascular Malformation (CVM)transposition of the great arteries (TGA)hypoplastic left heart syndrome (HLHS)
Beyond the preview
Go deeper on MOH_2018-06-30_002484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-06-30_002484.